QCI Interpret for Oncology

Agilent Alissa to QCI Interpret: How can your lab reduce the stress and complexity of transitioning to a new clinical informatics platform?

March 26, 2024
In 2023, Agilent announced the discontinuation of their Alissa Interpret clinical informatics platform by the end of 2024. As a result, many of their current customers need to transition to a new variant interpretation and reporting software within a tight timeframe. However, when evaluating new interpretation solutions, clinical labs must consider a variety of factors, including:

Content quality for clinical reporting
Flexibility to adapt current workflows to a new platform
Retaining historical content and comments
Ease of personnel training

In this webinar, learn about QCI Interpret, a panel- and sequencer-agnostic clinical informatics platform for NGS variant interpretation and reporting of germline and somatic tests. Our experts will address the concerns of current Alissa users and discuss what sets QCI Interpret apart from other interpretation solutions. In addition, we will show you how seamless it is to transition to QCI Interpret, as well as provide a live demonstration of the industry-leading and reliable software that has been used to analyze and interpret more than 3.5 million patient test cases worldwide.

Related videos

QCI Interpret for Oncology

How to scale-up comprehensive genomic profiling and deliver confident variant interpretations...

116 views November 10, 2023

As gene panels increase in size, comprehensive genomic profiling and variant...

QCI Interpret for Oncology

Comprehensive Molecular Tumor Analysis with Alacris Theranostics

247 views March 09, 2023

Precision oncology approaches have made great strides harnessing individual...

QCI Interpret for Oncology

Managing multiple biomarker therapeutic development

390 views September 12, 2019

For the past two decades, the paradigm in the field has been “one biomarker,...

Real-World Insights

Real-World Applications of Clinical Metagenomic Sequencing in Cancer and Infectious Disease...

174 views October 31, 2023

Clinical metagenomic next-generation sequencing (mNGS), the comprehensive...